Skip directly to search
Skip directly to A to Z list
Skip directly to navigation
Skip directly to page options
Skip directly to site content
Start of Search Controls
Search Form Controls
Search The CDC
submit
CDC A-Z Index
MENU
CDC A-Z
SEARCH
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Search Form Controls
Search The CDC
submit
CDC A-Z Index
Public Health Genomics and Precision Health Knowledge Base (v9.0)
PHGKB
About
Public Health Genomics Branch
PHGKB Weekly Horizon Scan
Genomics Precision Health Scan
Advanced Molecular Detection Clips
Non-Genomics Precision Health Scan
CDC-authored Publications Scan
Specialized PHGKB
Cancer PHGKB
Diabetes PHGKB
Economic Evaluation PHGKB
Environmental Health PHGKB
Family Health History PHGKB
Health Equity PHGKB
HLBS-PopOmics
Infectious Diseases PHGKB
Implementation Science PHGKB
Neurological Disorders PHGKB
Pharmacogenomics PHGKB
Primary Immune Deficiency Diseases PHGKB
Rare Diseases PHGKB
Reproductive and Child Health PHGKB
All Databases
COVID-19 GPH (47384)
CDC/NIH Web Information Database (32170)
CDC-Authored Genomics and Precision Health Publications Database (5894)
Precision Health Database (63623)
Tier-Classified Guidelines Database (533)
Pathogen Advanced Molecular Detection Database (26729)
All of Us Reports and Publications Database (656)
Human Genome Epidemiology
Human Genome Epidemiology Literature Finder (226219)
Epigenetic Epidemiology Publications Database (22714)
Release Note
Contact Us
Precision Health Database
Precision Health Database|Search|Public Health Genomics and Precision Health Knowledge Base (PHGKB)
Rare Diseases
Last data update: Apr 18, 2024
. (Total: 63623 Documents since 2012)
All
Cancer
Diabetes
Economic
Environmental
Equity
FHH
HLBS
ID
Implementation
ND
PGx
PI
Rare
RCH
dataset
All
GPH
Non-GPH
Filtered By
:
Select to fine-tune your search
Disease
Gene
Product Type
Category
Year
Previous
Records 1 - 30 (of 32 Records)
Next
Query Trace:
B-cell Lymphoma[original query]>>Original Studies[Product Type]
Integrated Genomic DNA/RNA Profiling vs Fluorescence in Situ Hybridization in the Detection of MYC and BCL2 (and BCL6) Rearrangements in Large B-Cell Lymphomas: Updates Amid the New WHO Classification of Lymphoid Neoplasms.
Luiz Paulo de Lima Guido et al. American journal of clinical pathology 2023
Similar articles in PubMed
Mutation analysis performed on tumor biopsies from patients with newly-diagnosed germinal center aggressive B cell lymphomas.
Landsburg Daniel J et al. Oncotarget 2022 131237-1244
Similar articles in PubMed
Multimodal deep learning model on interim [F]FDG PET/CT for predicting primary treatment failure in diffuse large B-cell lymphoma.
Yuan Cheng et al. European radiology 2022
Similar articles in PubMed
Budget Impact Analysis of CAR T-cell Therapy for Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma in Germany.
Skalt Daniela et al. HemaSphere 2022 6(7) e736
Similar articles in PubMed
Optimal PET-based radiomic signature construction based on the cross-combination method for predicting the survival of patients with diffuse large B-cell lymphoma.
Jiang Chong et al. European journal of nuclear medicine and molecular imaging 2022
Similar articles in PubMed
Artificial intelligence-assisted mapping of proliferation centers allows the distinction of accelerated phase from large cell transformation in chronic lymphocytic leukemia.
El Hussein Siba et al. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2022
Similar articles in PubMed
B-cell lymphoma 6 expression is not associated with live birth in a normal responder in vitro fertilization population.
Klimczak Amber M et al. Fertility and sterility 2021
Similar articles in PubMed
CT-based radiomics model with machine learning for predicting primary treatment failure in diffuse large B-cell Lymphoma.
Santiago Raoul et al. Translational oncology 2021 14(10) 101188
Similar articles in PubMed
Artificial intelligence to detect MYC translocation in slides of diffuse large B-cell lymphoma.
Swiderska-Chadaj Zaneta et al. Virchows Archiv : an international journal of pathology 2020 Sep
Similar articles in PubMed
Prognostic Significance of MYC Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium.
Rosenwald Andreas et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2019 37(35) 3359-3368
Similar articles in PubMed
Clinical utility of target capture-based panel sequencing in hematological malignancies: a multicenter feasibility study.
Yasuda Takahiko et al. Cancer science 2020 Jul
Similar articles in PubMed
Classifying 2-year recurrence in patients with dlbcl using clinical variables with imbalanced data and machine learning methods.
Wang Lei et al. Computer methods and programs in biomedicine 2020 Jun 196105567
Similar articles in PubMed
Deep learning shows the capability of high-level computer-aided diagnosis in malignant lymphoma.
Miyoshi Hiroaki et al. Laboratory investigation; a journal of technical methods and pathology 2020 May
Similar articles in PubMed
The application of antigen receptor gene rearrangement of BIOMED-2 in the pathologic diagnosis of 348 cases with non-Hodgkin lymphoma in a single institution in Southwest of China.
Liu Xueni et al. Pathology, research and practice 2019 Nov 215(11) 152615
Similar articles in PubMed
Optimizing Outcome Prediction in Diffuse Large B-Cell Lymphoma by Use of Machine Learning and Nationwide Lymphoma Registries: A Nordic Lymphoma Group Study.
Biccler Jorne L et al. JCO clinical cancer informatics 2018 21-13
Similar articles in PubMed
Gene expression profiles analysis identifies a novel two-gene signature to predict overall survival in diffuse large B-cell lymphoma.
Sun Chengtao et al. Bioscience reports 2019 39(1)
Similar articles in PubMed
The Use of Optimal Treatment for DLBCL Is Improving in All Age Groups and Is a Key Factor in Overall Survival, but Non-Clinical Factors Influence Treatment.
Wong Doo Nicole et al. Cancers 2019 Jul 11(7)
Similar articles in PubMed
Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction.
Kurtz David M, et al. Cell 2019 7 0. (3) 699-713.e19
Similar articles in PubMed
Clinical Significance of BCL2 , C- MYC , and BCL6 Genetic Abnormalities, Epstein-Barr Virus Infection, CD5 Protein Expression, Germinal Center B Cell/Non-Germinal Center B-Cell Subtypes, Co-expression of MYC/BCL2 Proteins and Co-expression of MYC/BCL2/BCL6 Proteins in Diffuse Large B-Cell Lymphoma: A Clinical and Pathological Correlation Study of 120 Patients.
Ting Choo-Yuen et al. International journal of medical sciences 2019 16(4) 556-566
Similar articles in PubMed
MYD88 mutations identify a molecular subgroup of diffuse large B-cell lymphoma with an unfavourable prognosis.
Vermaat Joost S et al. Haematologica 2019 May
Similar articles in PubMed
Automated Diagnosis of Lymphoma with Digital Pathology Images Using Deep Learning.
Achi Hanadi El et al. Annals of clinical and laboratory science 2019 Mar 49(2) 153-160
Similar articles in PubMed
Examination of the Biomark assay as an alternative to Oncotype DX for defining chemotherapy benefit.
Kim Jinkyoung et al. Oncology letters 2019 Feb 17(2) 1812-1818
Similar articles in PubMed
Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study.
Dunleavy Kieron et al. The Lancet. Haematology 2018 Dec 5(12) e609-e617
Similar articles in PubMed
Determination of CEBPA mutations by next generation sequencing in pediatric acute leukemia.
Akin D F et al. Bratislavske lekarske listy 2018 119(6) 366-372
Similar articles in PubMed
Mutation screening using formalin-fixed paraffin-embedded tissues: a stratified approach according to DNA quality.
Cucco Francesco et al. Laboratory investigation; a journal of technical methods and pathology 2018 May
Similar articles in PubMed
Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study.
Marchesi Francesco et al. Journal of experimental & clinical cancer research : CR 2018 May 37(1) 95
Similar articles in PubMed
The Impact of Drug Metabolism Gene Polymorphisms on Therapeutic Response and Survival in Diffuse Large B-Cell Lymphoma Patients.
Pál Ildikó et al. The Israel Medical Association journal : IMAJ 2018 Apr 20(4) 217-221
Similar articles in PubMed
Single-agent panobinostat for relapsed/refractory diffuse large B-cell lymphoma: clinical outcome and correlation with genomic data. A phase 2 study of the Fondazione Italiana Linfomi.
Zaja Francesco et al. Leukemia & lymphoma 2018 Apr 1-7
Similar articles in PubMed
Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma Highlights Molecular Divergence and Therapeutic Opportunities: a LYSA Study.
Dubois Sydney et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2016 Jun 22(12) 2919-28
Similar articles in PubMed
ABCG2 and NCF4 polymorphisms are associated with clinical outcomes in diffuse large B-cell lymphoma patients treated with R-CHOP.
Liu Duo et al. Oncotarget 2017 Aug 8(35) 58292-58303
Similar articles in PubMed
File Formats Help:
How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?
Adobe PDF file
Microsoft PowerPoint file
Microsoft Word file
Microsoft Excel file
Audio/Video file
Apple Quicktime file
RealPlayer file
Text file
Zip Archive file
SAS file
ePub file
Page last reviewed:
Feb 1, 2024
Page last updated:
Apr 18, 2024
Content source:
Public Health Genomics Branch in the Division of Blood Disorders and Public Health Genomics
,
National Center on Birth Defects and Developmental Disabilities
TOP